Jasper Therapeutics appoints Edwin Tucker as CMO

Jasper Therapeutics announced the appointment of Edwin Tucker as Jasper’s CMO. Concurrently, Jasper also announced the appointment of Dr. Daniel Adelman, who had been serving as Jasper’s Acting CMO, to its Scientific Advisory Board and to the position of Senior Clinical Advisor. Tucker was most recently Chief Medical Officer at Goldfinch Bio, where he led clinical development and helped build the regulatory, medical affairs and clinical operations functions.